|
|
|
Gout Clinical Trials, Diagnosis, and Treatment |
|
Thank you for your interest in clinical trials for Gout.
Please click "Search" to find Gout clinical trials and medical research studies
or read below for information on Gout diagnosis and treatment.
If you receive too many study listings you may enter your zip code to find the
locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 9 studies:
|
|
|
|
|
Results from other databases:
|
|
|
|
Your search returned 96 studies:
- Apremilast Therapy for Acute Gouty Arthritis - NCT00997581-03756
Conditions: Acute Gout Location: Lebanon, NH
- Efficacy and Safety of a Single Dose of ACZ885 in Hospitalized Patients With Acute Gout - NCT00663169-02115
Conditions: Arthritis, Gouty Location: Boston, MA
- Efficacy and Safety of a Single Dose of ACZ885 in Hospitalized Patients With Acute Gout - NCT00663169-08901
Conditions: Arthritis, Gouty Location: New Brunswick, NJ
- Efficacy and Safety of a Single Dose of ACZ885 in Hospitalized Patients With Acute Gout - NCT00663169-35249
Conditions: Arthritis, Gouty Location: Birmingham, AL
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-14609
Conditions: Gout Location: Rochester, NY
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-16635
Conditions: Gout Location: Duncansville, PA
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-29201
Conditions: Gout Location: Columbia, SC
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-29615
Conditions: Gout Location: Greenville, SC
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-33458
Conditions: Gout Location: Jupiter, FL
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-37601
Conditions: Gout Location: Johnson City, TN
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-48081
Conditions: Gout Location: St. Clair Shores, MI
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-66215
Conditions: Gout Location: Overland Park, KS
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-66606
Conditions: Gout Location: Topeka, KS
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-68134
Conditions: Gout Location: Omaha, NE
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-70809
Conditions: Gout Location: Baton Rouge, LA
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-71115
Conditions: Gout Location: Shreveport, LA
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-73103
Conditions: Gout Location: Oklahoma City, OK
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-74136
Conditions: Gout Location: Tulsa, OK
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-87102
Conditions: Gout Location: Albuquerque, NM
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-92108
Conditions: Gout Location: San Diego, CA
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-92646
Conditions: Gout Location: Huntington Beach, CA
- Long Term Study of Canakinumab (ACZ885) in Patients With Gout - NCT00927810-96814
Conditions: Gout Location: Honolulu, HI
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-01136
Conditions: Intercritical Gout Location: Resistertown, MD
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-06611
Conditions: Intercritical Gout Location: Trumball, CT
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-07728
Conditions: Intercritical Gout Location: Freehold, NJ
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-07922
Conditions: Intercritical Gout Location: Berkeley Heights, NJ
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-11201
Conditions: Intercritical Gout Location: Brooklyn, NY
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-16635
Conditions: Intercritical Gout Location: Duncansville, PA
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-17601
Conditions: Intercritical Gout Location: Lancaster, PA
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-18105
Conditions: Intercritical Gout Location: Fountain Hill, PA
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-19006
Conditions: Intercritical Gout Location: Huntingdon Valley, PA
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-21042
Conditions: Intercritical Gout Location: Ellicott City, MD
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-21286
Conditions: Intercritical Gout Location: Baltimore, MD
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-22015
Conditions: Intercritical Gout Location: Burke, VA
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-23219
Conditions: Intercritical Gout Location: Richmond, VA
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-27408
Conditions: Intercritical Gout Location: Greensboro, NC
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-27607
Conditions: Intercritical Gout Location: Raleigh, NC
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-27612
Conditions: Intercritical Gout Location: Raleigh, NC
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-28144
Conditions: Intercritical Gout Location: Salisbury, NC
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-28516
Conditions: Intercritical Gout Location: Morehead City, NC
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-28601
Conditions: Intercritical Gout Location: Hickory, NC
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-29406
Conditions: Intercritical Gout Location: Charleston, SC
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-29651
Conditions: Intercritical Gout Location: Greer, SC
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-29732
Conditions: Intercritical Gout Location: Rock Hill, SC
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-30084
Conditions: Intercritical Gout Location: Tucker, GA
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-30165
Conditions: Intercritical Gout Location: Rome, GA
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-30188
Conditions: Intercritical Gout Location: Woodstock, GA
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-30501
Conditions: Intercritical Gout Location: Gainsville, GA
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-32117
Conditions: Intercritical Gout Location: Daytona Beach, FL
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-32205
Conditions: Intercritical Gout Location: Jacksonville, FL
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-33446
Conditions: Intercritical Gout Location: Delray Beach, FL
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-33458
Conditions: Intercritical Gout Location: Jupiter, FL
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-33702
Conditions: Intercritical Gout Location: St. Petersburg, FL
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-38120
Conditions: Intercritical Gout Location: Memphis, TN
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-39202
Conditions: Intercritical Gout Location: Jackson, MS
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-42101
Conditions: Intercritical Gout Location: Bowling Green, KY
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-43551
Conditions: Intercritical Gout Location: Perrysburg, OH
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-44130
Conditions: Intercritical Gout Location: Middleburg Heights, OH
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-44313
Conditions: Intercritical Gout Location: Akron, OH
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-45246
Conditions: Intercritical Gout Location: Cincinnati, OH
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-46601
Conditions: Intercritical Gout Location: South Bend, IN
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-48098
Conditions: Intercritical Gout Location: Troy, MI
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-63031
Conditions: Intercritical Gout Location: Florissant, MO
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-67208
Conditions: Intercritical Gout Location: Wichita, KS
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-72143
Conditions: Intercritical Gout Location: Searcy, AR
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-75080
Conditions: Intercritical Gout Location: Richardson, TX
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-75224
Conditions: Intercritical Gout Location: Dallas, TX
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-75605
Conditions: Intercritical Gout Location: Longview, TX
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-77074
Conditions: Intercritical Gout Location: Houston, TX
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-78229
Conditions: Intercritical Gout Location: San Antonio, TX
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-83713
Conditions: Intercritical Gout Location: Boise, ID
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-85296
Conditions: Intercritical Gout Location: Gilbert, AZ
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-85381
Conditions: Intercritical Gout Location: Peoria, AZ
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-89123
Conditions: Intercritical Gout Location: Las Vegas, NV
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-89146
Conditions: Intercritical Gout Location: Las Vegas, NV
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-92103
Conditions: Intercritical Gout Location: San Diego, CA
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-93454
Conditions: Intercritical Gout Location: Santa Maria, CA
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-94520
Conditions: Intercritical Gout Location: Concord, CA
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-98405
Conditions: Intercritical Gout Location: Tacoma, WA
- PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations 1 - NCT00829829-99204
Conditions: Intercritical Gout Location: Spokane, WA
- Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE) - NCT00856206-
Conditions: Gout Location: Norfolk, VA
- Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout - NCT00985127-16635
Conditions: Gout Location: Duncansville, PA
- Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout - NCT00985127-27609
Conditions: Gout Location: Raleigh, NC
- Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout - NCT00985127-32720
Conditions: Gout Location: Deland, FL
- Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout - NCT00985127-40504
Conditions: Gout Location: Lexington, KY
- Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout - NCT00985127-57702
Conditions: Gout Location: Rapid City,
- Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout - NCT00985127-59715
Conditions: Gout Location: Bozeman, MT
- Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout - NCT00985127-68134
Conditions: Gout Location: Omaha, NE
- Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout - NCT00985127-73112
Conditions: Gout Location: Oklahoma City, OK
- Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout - NCT00985127-75235
Conditions: Gout Location: Dallas, TX
- Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout - NCT00985127-87106
Conditions: Gout Location: Albuquerque, NM
- Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout - NCT00985127-92618
Conditions: Gout Location: Irvine, CA
- Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout - NCT00985127-96814
Conditions: Gout Location: Honolulu, HI
- Study Utilizing Rilonacept in Gout Exacerbations - NCT00855920-
Conditions: Acute Gout Flare Location: Mesquite, TX
- Study Utilizing Rilonacept in Gout Exacerbations - NCT00855920-27612
Conditions: Acute Gout Flare Location: Raleigh, NC
- Study Utilizing Rilonacept in Gout Exacerbations - NCT00855920-48221
Conditions: Acute Gout Flare Location: Detroit, MI
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|